Referenten/innen

Kontakt

Administratives Sekretariat
Organizers Schweiz GmbH
+41 (0)61 836 98 78
public-health@organizers.ch

Downloads

Programm Lageplan

Link

Zurück zur Übersicht

 

Prof. Dr. Michael J. Barry
Chief General Medicine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, USA

Dr. Michael Barry became the Foundation for informed Medical Decision Making’s president in 2009. He has been involved with the Foundation since its beginning and previously served as Chief Medical Editor. He is a past President of the Society for Medical Decision-Making (SMDM) and the Society of General Internal Medicine. Dr. Barry has led many prominent research studies including the Patient Outcome Research Team for Prostatic Diseases. His research interests have included defining the outcomes of different strategies for the evaluation and treatment of prostate disease, decision analysis, health status measurement, clinical quality improvement, and the use of decision aids to facilitate patients’ participation in decision-making. Dr. Barry continues to practice primary care and serves as Medical Director of the John D. Stoeckle Center for Primary Care Innovation at the Massachusetts General Hospital, and Professor of Medicine at Harvard Medical School.

Prof. Dr. Bettina Borisch
Institut de médecine sociale et préventive, Université Genève
Prof. Dr. Pascal Bovet
Maître d'enseignement et de recherche, Institut universitaire de médecine sociale et préventive, Lausanne
Dr. Carlo Conti
Regierungsvizepräsident Kanton Basel-Stadt
Botschafter Dr. Martin Dahinden
Direktor DEZA - Direktion für Entwicklung und Zusammenarbeit, Bern

Prof. Dr. Sabina de Geest
Vorsteherin Institut für Pflegewissenschaft, Uni Basel

Sabina De Geest is a Professor of Nursing and Director of the Institute of Nursing Science of the Faculty of Medicine at the University of Basel, Switzerland and Chair of the Department of Public Health. Sabina De Geest leads the Leuven Basel Adherence Research Group, an international interdisciplinary research group focusing on behavioral and psychosocial issues, with the ultimate goal of improving clinical outcomes in chronically ill patient populations (e.g., solid organ & stem cell transplantation, HIV-AIDS, glaucoma). Sabina De Geest is also co-investigator and chairs the Psychosocial Interest Group of the Swiss Transplant Cohort Study, a nation-wide cohort study that started in May 2008. She heads the BRIGHT initiative, an international study exploring the relationship between broad system factors and medication adherence in transplant recipients in Europe and North America.

Dr. Hans Kluge
Director, Division of Health Systems and Public Health,
WHO Regional Office Europe, Copenhagen, Denmark

Dr Hans Kluge, is a Belgian trained medical doctor with a Masters degree in Public Health. Previously based in the WHO Country Office in Myanmar and the WHO Director-General’s Special Representative Office in Russia, he has a wealth of country and management experience spanning several WHO Regions with a background of both health systems, public health and infectious diseases.

Hans moved to the Regional Office, Copenhagen in 2009 when he was recruited to the position of Unit Head, Country Policies and Systems and has since worked as the Regional Director’s Special Representative to Combat M/XDR-TB in the European Region and most recently as Director, Division of Health Systems and Public Health. He is based in the WHO Regional Office for Europe.

Prof. Dr. Nino Künzli
Vize-Direktor Swiss TPH, Basel

Nino Künzli, MD, PhD, Chair (Ordinarius) of Public Health at the University Basel Medical School, is the Deputy Director of the Swiss Tropical and Public Health Institute Basel, Switzerland (www.swisstph.ch) and head of the Department of Epidemiology and Public Health. He was ICREA Research Professor at the Centre for Research in Environmental Epidemiology CREAL in Barcleona, Spain (2006-2009), and tenured Associate Professor at University of Southern California Keck School of Medicine Los Angeles (2002-2005). His research focus is environmental epidemiology with an emphasis on chronic diseases and air pollution epidemiology, including related exposure and public health risk assessment. Novel ongoing projects in Los Angeles, Spain, and Switzerland investigate in particular the role of ambient air pollution in atherosclerosis and inflammation among children, college students, and adults.

Künzli has a long-standing record in cohort-based research and a member of the Swiss SAPALDIA cohort study since its beginning in 1991. He worked and collaborates with the Southern Californian USC Children’s Health Study – the most important and largest air pollution related cohort study ever initiated with several cohorts recruited since its inception in 1992. Künzli is a steering committee member of both the European Community Respiratory Health Survey (ECRHS) cohort study http://www.ecrhs.org/ and the French study on the genetics of asthma EGEA to lead the air pollution related research agendas of these studies. He leads the Work Package 4 (WP4) on Respiratory Healthy among the new European consortium ESCAPE investigating the long-term effects of traffic-related air pollution http://www.escapeproject.eu/ , a consortium of >30 European cohorts brought together to investigate chronic effects or air pollution. WP4 will bring together 6 European cohorts, including ECRHS, SAPALDIA, two French (EGEA, E3N), a German (SALIA), and the British 1946 Cohort to investigate asthma, lung function, COPD, and respiratory symptoms.

Künzli is also engaged in the application of air pollution research findings to public health impact assessment as a tool to advice and inform policy makers. He conducted several international, national, regional or local air pollution impact assessment studies, and was a member of the 2001 Global Burden of Disease outdoor air pollution group.

Dr. Künzli received his M.D. from the University of Basel and his M.P.H. and Ph.D. from the University of California at Berkeley. Nino.Künzli@unibas.ch

Prof. Dr. Nicole Probst-Hensch
Head Unit Chronic Disease Epidemiology, Swiss Tropical and Public Health Institute, Basel

Curriculum Vitae

 

Silvia Schenker
Nationalrätin, Präsidentin GELIKO

Dr. Thomas Steffen
Leiter Abteilung Gesundheits­förderung, Gesundheitsdienste, Kanton Basel-Stadt

Thomas Steffen wurde am 21. Februar 1961 in Basel geboren. Nach Studienabschluss (1990) in Humanmedizin an der Universität Basel bildete er sich zum Facharzt für Prävention und Gesundheitswesen (2000) weiter. 1998 schloss er seine postgraduierte, universitäre  Weiterbildung mit dem Master of Public Health Titel ab. Thomas Steffen hat einen Lehrauftrag im Bereich Public Health an der Universität Basel und ist Präsident des Beirates der Sitftung Gesundheitsförderung Schweiz. Thomas Steffen ist Autor verschiedenster Fachpublikationen im Bereich Gesundheitsförderung und Prävention.

Nach seiner klinischen, ärztlichen Weiterbildung (Innere Medizin, Geriatrie und medizinische Rehabilitation) arbeitete er 1994 / 95 als wissenschaftlicher Adjunkt der Programmleitung des nationalen Forschungsprogramms 26A (die Gesundheit des Menschen in der heutigen Umwelt: Physische Umwelt) am Institut für Sozial- und Präventivmedizin der Universität Basel. Von 1996 bis 2000 war er am Institut für Suchtforschung, Zürich zuletzt als Forschungsleiter tätig. Er war in dieser Funktion auch Mitverantwortlich für die Evaluation der heroingestützten Therapie (PROVE / HeGeBe) in der Schweiz. 2000/01 entwickelte er als Klinikmanager am Kantonsspital Olten ein neues Qualitätsmanagement-System. 2001 bis 2003 arbeitete er als Sektionschef Präventivmedizin und Gesundheitsförderung und als stv. Kantonsarzt des Kantons Aargau und entwickelte in dieser Zeit unter anderem ein neues kantonales Gesundheitsförderungskonzept.

Seit Januar 2003 leitet Thomas Steffen die Abteilung Gesundheitsförderung und Prävention mit dem Kinder- und Jugendgesundheitsdienst und der Gesundheitsförderung Basel-Stadt. Er vertritt in dieser Funktion auch den Kanton in verschiedenen kantonalen und nationalen Gremien.
Dr. Andreas Wallnöfer
Senior Vice President and Global Head of Development, F. Hoffmann-La Roche, Basel
Prof. Dr. Dr. H.-Erich Wichmann
Institutsleiter Institut für Epidemiologie, Helmholtz Zentrum, München

Curriculum Vitae

Ursula Zybach
Präsidentin, Public Health Schweiz